Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

VK2735

VANQUISH 1

Viking Therapeutics · Phase 3 · Active, not recruiting · Enrollment 4500

NCT07104500

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Placebo Assignmentn/rn/rn/rn/r
Active Assignment (Dose 1)n/rn/rn/rn/r
Active Assignment (Dose 2)n/rn/rn/rn/r
Active Assignment (Dose 3)n/rn/rn/rn/r

Not shown

  • Placebo Assignment: endpoint not reported
  • Active Assignment (Dose 1): endpoint not reported
  • Active Assignment (Dose 2): endpoint not reported
  • Active Assignment (Dose 3): endpoint not reported